Recently announced results from the REWIND and EMPRISE studies show heart protective effects of GLP1-agonist Trulicity and SGLT-2 inhibitor Jardiance in people with and without established heart disease
Source: Type 2 Diabetes Therapies Trulicity and Jardiance Show Heart-Protective Effects